NCCN now recognizes personalized, tumor-informed ctDNA-MRD as a prognostic and predictive biomarker in MIBC, extending ...

The CDC released updated operational guidance for investigating locally-acquired mosquito-transmitted malaria in the US.

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice Guidelines in Oncology ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces expanded availability of Precise MRD™, broadening availability to patients ...

Natera NTRA recently announced that Signatera has received PMDA approval in Japan for use in colorectal cancer (CRC) patients ...

As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How ...

The guidelines state that a test must be FDA-approved, personalized, tumor-informed, multiplex, and use PCR-NGS for ctDNA.

Mucor PCR testing of bronchoalveolar lavage (BAL) fluid showed high specificity in identifying invasive pulmonary mucormycosis (IPM) in lung transplant recipients, especially when used in conjunction ...

A simple PCR of mouth rinse may serve as a useful non-invasive test in diagnosing Pneumocystis pneumonia compared with ...

This article explores how advances in qPCR are improving speed, sensitivity, and portability, enabling faster diagnostics and ...

“Infectious diseases don’t respect borders,” says Khoa Thai, a clinical microbiologist at the Star-shl medical diagnostics laboratory in the Netherlands. To limit their spread, we need a globally ...